With a population of over 670 million people in ASEAN, the total number of patients experiencing rare diseases and conditions ...

A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is ...

The younger that someone is when certain illnesses hit, especially before puberty, the more severe symptoms may be. And while ...

Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and ...

Catherine “Cathie” Wood has been leading the investment management firm ARK Investment Management LLC ("ARK Invest") as its ...

Chris Stancel, who has served as a firefighter and first responder for 25 years, was diagnosed with Stage 4 kidney disease ...

Comedian Peter Kay made a TV appearance on BBC’s The One Show, announcing that all profits from his 2026 Better Late Than ...

The relocation of a brown bear called Rano from the Karachi Zoo to an Islamabad sanctuary is as much a glimmer of hope as it ...

A chance encounter at 2025 THON has connected a York Township family to the Penn State volleyball team, offering support ...

About Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX), is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track ...